You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Neurological conditions
  5. Multiple sclerosis

Fingolimod for the treatment of highly active relapsing–remitting multiple sclerosis

  • Technology appraisal guidance
  • Reference number: TA254
  • Published:  25 April 2012
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History

TA254 Multiple sclerosis (relapsing-remitting) - fingolimod: Appendix A - Decision paper presented to the Institute's Guidance Executive

TA254 Multiple sclerosis (relapsing-remitting) - fingolimod: Appendix A - Decision paper presented to the Institute's Guidance Executive TA254 Multiple sclerosis (relapsing-remitting) - fingolimod: Appendix A - Decision paper presented to the Institute's Guidance Executive
09 July 2013
(391.42 Kb 54 sec)

Adobe Acrobat reader required.

  Adobe Acrobat reader required.

This page was last updated: 08 July 2013

Back to top